The Chemical Screening Facility at CeMM provides internal and external researchers, as well as commercial project partners, with access to advanced chemical biology resources. These include a 100+k compound library and state-of-the-art high-throughput and high-content screening technologies, enabling the identification and characterization of small molecules that modulate novel biological targets. This supports the study of complex biological processes and the development of innovative therapeutic compounds.
A highly skilled and motivated team offers comprehensive support throughout all stages of the screening workflow—ranging from library and compound selection to assay planning, computational and wet-lab assay preparation, assay execution, and data analysis.
The facility offers a range of well-established routine screening assays, while also providing the flexibility to implement specialized methodologies and support for assay development and miniaturization.
Anna Koren
Biosketch
Anna Koren obtained her Master’s degree in Biotechnical Processes from the University of Applied Sciences (FH) Wiener Neustadt/Tulln in 2011. Afterwards, she worked as a research assistant in the Quality Control Clinical Serology department at Valneva Austria GmbH, mainly focusing on assay development and testing of clinical samples in a GCLP environment. In 2014, Anna joined CeMM as a Technical Assistant in Stefan Kubiceks lab and the Chemical Screening Platform (PLACEBO), where she took over the position as Head of Chemical Screening in September 2020. She is an expert in cellular and biochemical high-throughput and high-content screening and, together with her team, has supported numerous research projects within CeMM but also with external collaboration partners.
Contact
+43-1/40160-70 061
Send an e-mail
People
